NORDIC BIOSITE ApS: Financial statements 2025
CVR: 30711572
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
NORDIC BIOSITE ApS (CVR 30711572) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 6,639,125 and a net result of DKK 1,220,258 compared with DKK 1,205,660 the year before. That is an increase of 0.9% compared with the year before. Equity in the 2025 report amounted to DKK 1,808,346. The solvency ratio was 48.1%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 6,639,125
- Profit/Loss
- DKK 1,220,258
- Equity
- DKK 1,808,346
- Total Assets
- DKK 3,763,159
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 6.6M | 1.2M | 1.8M | 3 |
| 2024 | - | 6.6M | 1.2M | 2.1M | 3 |
| 2023 | - | 4.4M | 2.5M | 3.4M | 2 |
| 2022 | - | 4.1M | 1.8M | 2.4M | 2 |
| 2021 | - | 4.1M | 1.2M | 2.4M | 3 |
Official annual report
How creditworthy is NORDIC BIOSITE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of November 17, 2025, KPMG P/S has been appointed auditor of NORDIC BIOSITE ApS.
As of November 17, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of NORDIC BIOSITE ApS.
As of November 12, 2025, Sune Schmølker has left the board of directors of NORDIC BIOSITE ApS.
As of November 12, 2025, Sune Schmølker has stepped down as director of NORDIC BIOSITE ApS.
NORDIC BIOSITE ApS has published its annual report for 2024. Gross profit came to DKK 6,582,661, and the net result was DKK 1,205,660.
As of April 1, 2025, Sara Sadi Varnam Khasti is registered as director of NORDIC BIOSITE ApS.
As of April 1, 2025, Camilla Eva Duborn has stepped down as director of NORDIC BIOSITE ApS.
About NORDIC BIOSITE ApS
NORDIC BIOSITE ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2007. The company is registered under the industry Aktiviteter inden for hospitalsvæsen. The management consists of Rasmus Valdemar Lind. The board consists of Rasmus Valdemar Lind (chair) and Claudia Maria Carolina Berron Osorno. The company is owned by Nordic Biosite AB. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 6,639,125 and a net result of DKK 1,220,258 compared with DKK 1,205,660 the year before. Equity in the 2025 report amounted to DKK 1,808,346.